AI-generated summary
The authors describe LION, a fully remote, sham-controlled randomized trial of morning bright light therapy versus a deactivated negative ion generator for sleep in Veterans with mild traumatic brain injury. The protocol was designed to test feasibility and acceptability, and the authors report that dropout was under 10 percent, missing data under 15 percent, and adherence above 85 percent. The study was not designed to establish efficacy.
- Who or what was studied
- Veterans with mild traumatic brain injury, with and without TBI, enrolled remotely within the VA
- Limits stated in the abstract
- The authors state that the preceding pilot was single-arm, open-label and non-randomized, and that this protocol is intended to establish feasibility and acceptability rather than efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on medrxiv.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Traumatic brain injury, Sham, Randomized controlled trial, Bright light therapy, Brain injury. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.